from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2319c/-

LFCtreatmentdescriptionclass of inhibitor

0.697

Amikacinug/mL Amikacintranslation

1.238

Cap5-10ug/mL Capreomycintranslation

0.662

Rox10-50 ug/mL Roxithromycintranslation

0.726

SM2-5 ug/mL Streptomycintranslation

0.597

Tet5-10 ug/mL Tetracyclinetranslation

0.681

Rif0.2-5ug/mL Rifampicintranscription

0.414

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.314

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.754

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.357

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.616

Clofazimine10-13 ug/mL Clofaziminerespiration

0.271

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.104

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.130

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.217

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.522

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.888

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.729

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.695

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.249

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.497

Nigericin50 uM Nigericinrespiration

0.422

TRC10-150 ug/mL Triclosanrespiration

-0.431

TRZ10-25 ug/mL Thioridazinerespiration

-0.574

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-2.048

menadione6-10 ug/mL Menadionerespiration

-0.159

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.125

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.057

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.799

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.283

NRP_1Non-replicating persistence stage 1dosRassociated

-0.419

Amp0.2mg/mL AmpicillincellWall

-1.077

Cephalexin20-100 ug/mL CephalexincellWall

0.408

Cerulenin0.32-5 ug/mL CerulenincellWall

0.418

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.617

EMB10-20 ug/mL EthambutolcellWall

-0.332

Eta12-40 ug/mL EthionamidecellWall

-0.052

INH0.2-0.4 ug/mL IsoniazidcellWall

0.142

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.235

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.635

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.070

BZA0.12 mg/mL BenzamidearomaticAmides

0.837

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.280

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.834

H2O24 mM hydrogen peroxideDNAdamaging

-0.141

Levo10 ug/mL LevofloxacinDNAdamaging

0.503

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.413

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.461

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.102

UVUV-irradiationDNAdamaging

-1.291

ARP41-4 ug/mL Antitubercular compound ARP4?

1.074

Antimycin12.5-50 ug/mL Antimycin A?

-1.074

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.161

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.043

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.089

PA8240.2-2 ug/mL PA-824?

0.347

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.368

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.650

Verapamil50 uM Verapamil?

-0.608

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.356

methoxatin10-20 ug/mL Methoxatin?